We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Hand-Held Blood Analyzer Receives CE Mark

By LabMedica International staff writers
Posted on 15 Dec 2016
Print article
Image: The easy-to-use i-STAT Alinity handheld operates with the advanced technology of single-use i-STAT test cartridges (Photo courtesy of Abbott).
Image: The easy-to-use i-STAT Alinity handheld operates with the advanced technology of single-use i-STAT test cartridges (Photo courtesy of Abbott).
Globally, demand for healthcare is growing as people live longer, chronic diseases are more prevalent and people are more involved in decisions pertaining to their health. As more people access care, health systems, hospitals and other clinical care settings are challenged to keep pace and find resourceful, efficient and cost-effective ways to provide quality care.

In today's pressure-packed healthcare environment, clinicians rely on easy-to-use testing technologies that do not require complex training. Innovative point of care testing tools can help address this need and provide a simpler experience for those who use it, allowing them to accurately diagnose and treat patients faster and more efficiently.

An innovative, handheld blood-testing platform has received the CE Mark and is now for sale in Europe and other countries that recognize CE Mark. The portable device can perform and analyze the largest menu of blood tests on a single device, ranging from blood chemistries to cardiac markers, using only two to three drops of a person's blood. Delivering results in two to 10 minutes, the device equips healthcare professionals with the information they need to make fast and accurate medical decisions without ever leaving their patient's side. Its advanced connectivity features allow testing to be conducted virtually anywhere.

The i-STAT Alinity System (Abbott Point of Care Inc, Princeton, NJ, USA) returns results within two to 10 minutes and can run tests including blood chemistry and cardiac biomarkers. The system features expansive testing menu capabilities to enable the most combinations of tests in a single cartridge and new types of tests in the future, including tests for brain injury, infectious disease and oncology. Advanced quality control features designed with patient safety and regulatory compliance in the forefront; wireless or hard-wired connectivity so healthcare providers can manage diagnostic data and oversight with the broader healthcare system's network.

The system also features a large, bright, color touchscreen with graphics-driven, on-screen guidance and advanced light and sound notifications that alert clinicians with critical information. An ergonomic design with easy-grip handling that is balanced, comfortable and secure and durable materials designed to prevent damage from drops and harsh cleaning substances commonly used in clinical settings.

Matt Bates, PhD, divisional vice president of research and development at Abbott’s Point of Care Diagnostics division, said, “We spent countless hours doing on-the-ground research with doctors, nurses, lab directors, point of care coordinators and other customers from around the world. We asked about their pain points and listened to what they want and need for testing. Using these customer insights, Abbott designed and built i-STAT Alinity for better access, efficiency and speed to improve clinical decision making and positively impact patients' lives.”

Related Links:
Abbott Point of Care
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: Fingertip blood sample collection on the Babson Handwarmer (Photo courtesy of Babson Diagnostics)

Unique Hand-Warming Technology Supports High-Quality Fingertip Blood Sample Collection

Warming the hand is an effective way to facilitate blood collection from a fingertip, yet off-the-shelf solutions often do not fulfill laboratory requirements. Now, a unique hand-warming technology has... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.